Mother’s Milk Sugars: New Class Of Antibacterial Agents
Sugars in mother’s’ milk do not just provide nutrition for babies but also help protect them from bacterial infections, making them a new class of antimicrobial agent, a new study has found.
Previously, scientists have concentrated their search for the source of human mother’s milk’s antibacterial properties on the proteins it contains. However, an interdisciplinary team of chemists and doctors at Vanderbilt University have discovered that some of the carbohydrates in human milk not only possess antibacterial properties of their own but also enhance the effectiveness of the antibacterial proteins also present.
“This is the first example of generalized, antimicrobial activity on the part of the carbohydrates in human milk. One of the remarkable properties of these compounds is that they are clearly non-toxic, unlike most antibiotics,”
said Assistant Professor of Chemistry Steven Townsend, who directed the study.
The research was motivated by the growing problem of bacterial resistance to antibiotics, which the Center for Disease Control and Prevention estimates causes 23,000 deaths annually.
“We started to look for different methods to defeat infectious bacteria. For inspiration, we turned to one particular bacteria, Group B Strep. We wondered whether its common host, pregnant women, produces compounds that can either weaken or kill strep, which is a leading cause of infections in newborns worldwide,”
Image on the left illustrates how Strep bacteria normally clump together to form a protective biofilm. The image of the right shows that the biofilm breaks down when a Strep culture is dosed with human milk sugars, exposing more of the bacteria to attack by antibacterial agents. Credit: Steven Townsend, Vanderbilt University
Instead of searching for proteins in human milk with antimicrobial properties, Townsend and his colleagues turned their attention to the sugars, which are considerably more difficult to study.
“For most of the last century, biochemists have argued that proteins are most important and sugars are an afterthought. Most people have bought into that argument, even though there’s no data to support it,” Townsend said. “Far less is known about the function of sugars and, as a trained glycoprotein chemist, I wanted to explore their role.”
To do so, the researchers collected human milk carbohydrates, also called oligosaccharides, from a number of different donor samples and profiled them with a mass spectrometry technique that can identify thousands of large biomolecules simultaneously. Then they added the compounds to strep cultures and observed the result under the microscope.
This showed that not only do some of these oligosaccharides kill the bacteria directly but some also physically break down the biofilms that the bacteria form to protect themselves.
In a pilot study, Townsend’s lab collected five samples. They found that the sugars from one sample nearly killed an entire strep colony.
In another sample, the sugars were moderately effective while the remaining three samples exhibited a lower level of activity. In a follow-up study, they are testing more than two dozen additional samples.
So far, two broke down the bacterial biofilms and killed the bacteria, four broke down the biofilms but did not kill the bacteria and two killed the bacteria without breaking down the biofilms.
“Our results show that these sugars have a one-two punch,” said Townsend. “First, they sensitize the target bacteria and then they kill them. Biologist sometimes call this ‘synthetic lethality’ and there is a major push to develop new antimicrobial drugs with this capability.”
By dosing strep cultures with a mixture of milk sugars and antimicrobial peptides from human saliva, the researchers also showed that the sugars’ ability to break down biofilms can also enhance the effectiveness of the other antimicrobial agents that breast milk contains.
In follow-up studies the team has also shown that the milk sugars’ antimicrobial activity extends to a number of other infectious bacteria, including two of the six “ESKAPE” pathogens that are the leading cause of hospital infections worldwide.
Townsend is collaborating with colleagues in Vanderbilt’s Mass Spectrometry Research Center to identify the specific types of carbohydrate molecules responsible for the antibacterial effects they have discovered.